Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04319809 · ClinicalTrials.gov registry record · NA
Object Finder for a Retinal Prosthesis
A NA study of Retinitis Pigmentosa, sponsored by Minnesota HealthSolutions.
- Completed
- Registry status
- NA
- Development phase
- 9
- Enrollment target
- 1
- Study location
NCT04319809: Completed NA study of Retinitis Pigmentosa, sponsored by Minnesota HealthSolutions.
NCT04319809 is a NA study of Retinitis Pigmentosa that has completed, run by Minnesota HealthSolutions. The registered enrollment target is 9 participants, below the 261-participant average among 37 other Retinitis Pigmentosa trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04319809, a NA study of Retinitis Pigmentosa, has completed, sponsored by Minnesota HealthSolutions.
- COMPLETED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
- 1
- Study location
Study Summary
The proposed project seeks to provide object recognition as a feature in a retinal implant system. Participants will be able to direct an object recognition application to find a desired object in the field of view of the head-mounted camera, and to direct the participant's view towards it through the presentation of a recognizable icon. A prototype system will be developed and evaluated in human subjects in phase I. A full system implementation and a second phase of the trial will be completed in phase II.
Primary Outcome
This outcome measure compares time to task completion without and with modalities of the subsystem for both a stationary and mobility task. For the stationary task, participants were seated in front of a table and a cell phone was placed randomly at the center of one of ten rectangular zones. Participants were asked to find and put their hand on the location of the cell phone. The time of the response was recorded (and the distance from the cell phone, which is a separate primary outcome). For t
Conditions Studied
Interventions
- DEVICE Object recognition subsystem
Study Locations (1)
Maryland
- Johns Hopkins Hospital - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2017-07-01 |
| Est. Completion | 2022-08-31 |
| Phase | NA |
What the finished NCT04319809 record still lists
NCT04319809 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 261-participant average among 37 other Retinitis Pigmentosa trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Retinitis Pigmentosa appearing as the primary indexed condition, and to 1 intervention - of which Object recognition subsystem is the first listed.
NCT04319809 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT04319809 about?
NCT04319809 is a clinical study titled "Object Finder for a Retinal Prosthesis". The proposed project seeks to provide object recognition as a feature in a retinal implant system. Participants will be able to direct an object recognition application to find a desired object in the field of view of the head-mounted camera, and to direct the participant's view towards it through t...
What is the current status of trial NCT04319809?
This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2017-07-01. Estimated completion is 2022-08-31.
What conditions does trial NCT04319809 study?
This clinical trial studies the following conditions: Retinitis Pigmentosa.
What interventions are being tested in trial NCT04319809?
The interventions under investigation include: Object recognition subsystem (DEVICE).
Who is sponsoring clinical trial NCT04319809?
This trial is sponsored by Minnesota HealthSolutions, which has 9 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04319809 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Retinitis Pigmentosa
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04319809's enrollment target sits among peer trials
9 36th of 37 higher than 2 of 37 other Retinitis Pigmentosa trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Retinitis Pigmentosa trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Stem Cell Ophthalmology Treatment Study II
RECRUITING · NA
-
Experimental and Clinical Studies of Retinal Stimulation
RECRUITING · NA
-
Electro-acupuncture and Transcorneal Electrical Stimulation (TES) for Retinitis Pigmentosa
ACTIVE NOT RECRUITING · NA
-
Prospective Natural History Study of Retinitis Pigmentosa
ACTIVE NOT RECRUITING · NA
-
Argus II/ORCAM Device Study
COMPLETED · NA
-
Computer-Assisted Rehabilitation Environment Training After Argus Retinal Prosthesis
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI